BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34369323)

  • 21. [Porphyrias-what is verified?].
    Stölzel U; Kubisch I; Stauch T
    Internist (Berl); 2018 Dec; 59(12):1239-1248. PubMed ID: 30328490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Givosiran for the treatment of acute hepatic porphyria.
    Ricci A; Ventura P
    Expert Rev Clin Pharmacol; 2022 Apr; 15(4):383-393. PubMed ID: 35531651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Guide and Update on Porphyrias.
    Stölzel U; Doss MO; Schuppan D
    Gastroenterology; 2019 Aug; 157(2):365-381.e4. PubMed ID: 31085196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute hepatic porphyria and cancer risk: a nationwide cohort study.
    Baravelli CM; Sandberg S; Aarsand AK; Nilsen RM; Tollånes MC
    J Intern Med; 2017 Sep; 282(3):229-240. PubMed ID: 28730628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances on porphyria genetics: Inheritance, penetrance & molecular heterogeneity, including new modifying/causative genes.
    Yasuda M; Chen B; Desnick RJ
    Mol Genet Metab; 2019 Nov; 128(3):320-331. PubMed ID: 30594473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical Diagnosis of Acute Hepatic Porphyria: Updated Expert Recommendations for Primary Care Physicians.
    Anderson KE; Lobo R; Salazar D; Schloetter M; Spitzer G; White AL; Young RM; Bonkovsky HL; Frank EL; Mora J; Tortorelli S
    Am J Med Sci; 2021 Aug; 362(2):113-121. PubMed ID: 33865828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythropoietic and hepatic porphyrias.
    Gross U; Hoffmann GF; Doss MO
    J Inherit Metab Dis; 2000 Nov; 23(7):641-61. PubMed ID: 11117426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical importance of early acute hepatic porphyria diagnosis: a national cohort.
    Edel Y; Mamet R; Cohen S; Shepshelovich D; Levi A; Sagy I
    Intern Emerg Med; 2021 Jan; 16(1):133-139. PubMed ID: 32372331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heme biosynthesis and the porphyrias.
    Phillips JD
    Mol Genet Metab; 2019 Nov; 128(3):164-177. PubMed ID: 31326287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurological Manifestations of Acute Porphyrias.
    Wylie K; Testai FD
    Curr Neurol Neurosci Rep; 2022 Jul; 22(7):355-362. PubMed ID: 35665475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk for incident comorbidities, nonhepatic cancer and mortality in acute hepatic porphyria: A matched cohort study in 1244 individuals.
    Lissing M; Vassiliou D; Floderus Y; Harper P; Yan J; Hagström H; Sardh E; Wahlin S
    J Inherit Metab Dis; 2023 Mar; 46(2):286-299. PubMed ID: 36546345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disease burden in patients with acute hepatic porphyria: experience from the phase 3 ENVISION study.
    Wang B; Ventura P; Takase KI; Thapar M; Cassiman D; Kubisch I; Liu S; Sweetser MT; Balwani M
    Orphanet J Rare Dis; 2022 Aug; 17(1):327. PubMed ID: 36028858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute Hepatic Porphyrias: "Purple Flags"-Clinical Features That Should Prompt Specific Diagnostic Testing.
    Anderson KE; Desnick RJ; Stewart MF; Ventura P; Bonkovsky HL
    Am J Med Sci; 2022 Jan; 363(1):1-10. PubMed ID: 34606756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimating the broader fiscal consequences of acute hepatic porphyria (AHP) with recurrent attacks in Belgium using a public economic analytic framework.
    Connolly MP; Kotsopoulos N; Vermeersch S; Patris J; Cassiman D
    Orphanet J Rare Dis; 2021 Aug; 16(1):346. PubMed ID: 34348763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experiences and concerns of patients with recurrent attacks of acute hepatic porphyria: A qualitative study.
    Naik H; Stoecker M; Sanderson SC; Balwani M; Desnick RJ
    Mol Genet Metab; 2016 Nov; 119(3):278-283. PubMed ID: 27595545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel treatment options for acute hepatic porphyrias.
    Wang B
    Curr Opin Gastroenterol; 2021 May; 37(3):194-199. PubMed ID: 33769375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alcohol and porphyrin metabolism.
    Doss MO; Kühnel A; Gross U
    Alcohol Alcohol; 2000; 35(2):109-25. PubMed ID: 10787385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A next-generation-sequencing panel for mutational analysis of dominant acute hepatic porphyrias.
    Barman-Aksözen J; Suter L; Wegmann F; Meienberg J; Minder AE; Beer M; Komminoth P; Minder EI; Schneider-Yin X
    Scand J Clin Lab Invest; 2019 Sep; 79(5):305-313. PubMed ID: 31154864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The acute hepatic porphyrias: current status and future challenges.
    Siegesmund M; van Tuyll van Serooskerken AM; Poblete-Gutiérrez P; Frank J
    Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):593-605. PubMed ID: 20955962
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.